Our
philosophy is to only acquire companies that will add significant
Gross Revenue, Net Profit and Shareholder Value to
FRLF
LAS
VEGAS, NV, Jan. 09, 2018 (NewMedaiWire) -- Freedom Leaf Inc. ®
(OTCQB:FRLF), The Marijuana Legalization Company
®, is pleased to report that it has fully acquired 100%
of Green Market Europe S.L. (GME), a
Spanish producer of hemp products. Since the
announcement of the acquisition, June 28th
2017, Freedom Leaf Inc. Officers have been diligently
working to finalize the international acquisition, and as of today
all relevant documentation has been submitted, signed, and
finalized.
Clifford
J. Perry, Co-founder and CEO of Freedom Leaf Inc., said, “We are
very pleased to have completed this transaction, the deal is now
final. Our philosophy is to only acquire companies that will add
significant Gross Revenue, Net Profit and Shareholder Value to
Freedom Leaf Inc. financials, and this is no exception. Green
Market Europe S.L. is projected to add €2.000.000 ($2,393,060USD)
in its first full year of operation at approximately a 15% net
profit.”
Green Market Europe S.L. facilities include a 21,000
sq. ft. light deprivation greenhouse, a 43,000 sq. ft. indoor
growing research facility, and over 200 acres of outdoor production
space. The light deprivation allows the increase of the number of
yearly crops from 3 to 4 crops a year, and the 43,000 sq. ft.
indoor grow facility is used for genetic research and cultivating
additional hemp crops. Green Market Europe S.L. is strategically
located in Elche, Alicante, an important Spanish business hub, with
great year-round weather conditions for agricultural growing and a
long tradition of growing hemp.
GME
marks the second completed acquisition for Freedom Leaf Inc. in
Spain and Europe. The first acquisition was in May 2017
of LaMarihuana.com, the Spanish-speaking community’s leading
cannabis portal, and Marihuana-Medicinal.com, an influential
Spanish medical cannabis information website. LaMarihuana.com was
founded in 2001 and currently has more than 1.7 million page visits
monthly, making it the among the most visited online portals
worldwide for the Spanish-speaking community. LaMarihuana.com also
has more than 1.3 million Facebook fans.
Freedom
Leaf, Inc. is currently collaborating with Spanish scientists
isolating other rare cannabinoids. Some of the ongoing research
includes strains with Tetrahydrocannabivarin (THCV), which
suppresses appetite, and Cannabichromene (CBC), which has been
shown to aid with depression.
Perry
has hailed Freedom Leaf Iberia
B. V. licensee’s Managing Director, Federico
Pando, for his work in bringing this and other
Spanish projects to fruition for Freedom Leaf Inc.
¨GME
will be an essential tool of FL to expand in the Medical Cannabis
and cannabinoid based therapy. The know-how of mass Cannabinoid
production, research and IP gives us a priceless competitive
advantage towards cooperating with Governments and Institutions to
bring Cannabinoid based therapy to medical patients,” stated by
Federico Pando.
Paul F. Pelosi, Jr., Freedom Leaf Inc Chairman of the
Board, added, “Freedom Leaf is staking its claim to foreign
markets. Starting with Europe and planning for Central and South
America expansion as well as other countries around the world. The
market for Industrial Hemp is expanding in many countries even
faster than the United States, and in many cases even faster than
marijuana. Major legal revenue streams are available from exploring
these different markets around the world.”
Green Market Europe S.L. has a current
collaboration agreement with Elche-based University of Miguel
Hernandez to grow and develop EU certified Hemp strains with high
cannabidiol (CBD) content that can easily grow in the local
climate, and for researching better methods for growing hemp.
The company is also collaborating with two privately owned European
companies for product development and global marketing to provide a
variety of Freedom Leaf branded products with Rare Cannabinoids,
CBG, (Cannabigerol) in addition to its popular CBD, Cannabidiol.
Other rare cannabinoids are also being developed
Although NO MEDICAL CLAIMS ARE BEING MADE FOR ANY OF THE
PRODUCTS, in various studies there are indications that
Cannabigerol may relieve pain, reduce seizures and convulsions,
slow bacterial growth in certain species, reduce inflammation
systemically, induce sleep, inhibit cancer cell growth, stimulate
the growth of new brain cells and promote bone growth. Some of the
other conditions under study include glaucoma, inflammatory bowel
diseases, anti-inflammatory disorders, epilepsy and chronic
pain.
About Freedom Leaf
Freedom
Leaf, Inc., The Marijuana Legalization Company®, is a fully
reporting and audited, publicly traded company trading under the
symbol (OTCQB: FRLF).
Freedom Leaf, Inc. is a leading go-to resource in the cannabis,
medical marijuana, and industrial hemp industry. It is involved in
mergers and acquisitions and business consulting in the marijuana
industry, including incubation/acceleration and spin offs of new
marijuana/hemp related companies.
Freedom
Leaf, Inc.’s flagship publication is Freedom Leaf Magazine,
“The Good News in Marijuana Reform.” The company produces a
portfolio of news, print and digital multi-media verticals,
websites, blogs and web advertising, for the ever-changing emerging
cannabis, medical marijuana and industrial hemp
industry.
Freedom Leaf, Inc. does not handle, grow, sell, or dispense
marijuana.
All of our European activities are in full compliance with relevant
EU laws.
Corporate Website and Investor
Relations www.FreedomLeafInc.com.
Safe Harbor Statement
Statements
in this press release that are not strictly historical are
“forward-looking” statements within the meaning of Section 27A of
the Securities Act of 1933, as amended and Section 21E of the
Securities Exchange Act of 1934, as amended. These forward-looking
statements, including any financial projections above, generally
can be identified by phrases such as Freedom Leaf, Inc. or its
management “believes,” “expects,” “anticipates,” “foresees,”
“forecasts,” “estimates” “projections” or other words or phrases of
similar import. Similarly, statements herein that describe the
Company’s business strategy, outlook, objectives, plans, intentions
or goals also are forward-looking statements. All such
forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially
from those in forward-looking statements. Factors that could cause
or contribute to differences include the uncertainty regarding
viability and market acceptance of the Company’s products and
services, changes in relationships with third parties, and other
factors described in the Company’s most recent periodic filings
with the Securities and Exchange Commission, including its Annual
Report on Form 10-K dated June 30, 2017 and quarterly reports on
Form 10-Q.
CONTACT INFORMATION
Raymond Medeiros
PR and Business Development Director
Phone: 415-601-1974
Ray@FreedomLeaf.com
Freedom Leaf, Inc.3571
East Sunset Road
Las Vegas, Nevada
89120